September 28, 2017
More physicians will soon be evaluating an innovative radio frequency (RF) needle developed by Baylis Medical Company Inc. as part of a cross-Canada clinical trial in people with atrial fibrillation (AF). It is the most common heart arrhythmia abnormality and accounts for the majority of arrhythmia-related emergency room visits and hospital admissions. Previous studies have...
Read More

Cardiac Arrhythmia
Network of Canada

1465 Richmond St.
3rd Floor
London, ON
N6G 2M1

519-661-2111 x80011